Gene Therapy: An Overview of Advances and Applications of Gene Therapies

  • HMX
Gene Therapy Course Icon

Registration Deadline: June 2

Registration Deadline: July 14

Group Enrollment Option A program that is a popular choice for organizations and institutions to purchase in bulk.

Deadline Approaching Enroll now to secure your seat.

Explore recent advances in gene therapy and learn about the implications for patient care.

  • Online; Instructor-Paced

Lessons are released weekly and remain available until the course ends.

 

Available Start Dates

June 9

July 21

$1,025

Multi-course bundle pricing is also available across enrollment periods.

Certificate

Earn a Certificate of Completion upon successfully completing all coursework.

10 Weeks, 1-2 Hours/Week

Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge and how carefully you take notes.

  • Online; Instructor-Paced

Lessons are released weekly and remain available until the course ends.

 

Available Start Dates

June 9

July 21

$1,025

Multi-course bundle pricing is also available across enrollment periods.

Certificate

Earn a Certificate of Completion upon successfully completing all coursework.

10 Weeks, 1-2 Hours/Week

Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge and how carefully you take notes.

On This Page

Overview

In recent years, close collaboration between multiple scientific disciplines has rendered gene therapy a viable treatment option for some genetic conditions, and a promising pursuit for many others such as various cancers, blood disorders, neurological diseases, and inherited retinal disorders. Advancements in vector science, gene editing technologies, and understanding of the molecular underpinnings of disease continue to pave the way for the development of additional gene therapy treatments aimed at improving patient quality of life and prolonging lifespan.  

In this advanced HMX course, you will gain an overview of the latest advancements in gene therapy and their transformative impact on patient care. Explore both in vivo and ex vivo gene augmentation strategies, as well as the types of vectors used in different approaches. You will build a strong understanding of the real-world applications of these groundbreaking therapies, including the development of gene therapies that are tailored to treat specific genetic disorders—or even just one patient. 

Learning Objectives

  • Learn the fundamental concepts of gene therapy including the different modalities, critical terminology, and necessary components
  • Gain an understanding of the key differences between ex vivo and in vivo gene therapies, including their unique uses, delivery methods, and challenges
  • See how ex vivo and in vivo gene therapies can be clinically applied to treat inherited genetic conditions

Who Should Participate

Clinicians and other medical professionals; researchers in biomedicine and industry sectors; professionals in biotechnology and health care-related fields

Overview

In recent years, close collaboration between multiple scientific disciplines has rendered gene therapy a viable treatment option for some genetic conditions, and a promising pursuit for many others such as various cancers, blood disorders, neurological diseases, and inherited retinal disorders. Advancements in vector science, gene editing technologies, and understanding of the molecular underpinnings of disease continue to pave the way for the development of additional gene therapy treatments aimed at improving patient quality of life and prolonging lifespan.  

In this advanced HMX course, you will gain an overview of the latest advancements in gene therapy and their transformative impact on patient care. Explore both in vivo and ex vivo gene augmentation strategies, as well as the types of vectors used in different approaches. You will build a strong understanding of the real-world applications of these groundbreaking therapies, including the development of gene therapies that are tailored to treat specific genetic disorders—or even just one patient. 

Learning Objectives

  • Learn the fundamental concepts of gene therapy including the different modalities, critical terminology, and necessary components
  • Gain an understanding of the key differences between ex vivo and in vivo gene therapies, including their unique uses, delivery methods, and challenges
  • See how ex vivo and in vivo gene therapies can be clinically applied to treat inherited genetic conditions

Who Should Participate

Clinicians and other medical professionals; researchers in biomedicine and industry sectors; professionals in biotechnology and health care-related fields

Questions?

Have questions about HMX courses, enrollment, or learning options? Contact our team by email—we’re happy to assist.

About the Course

HMX online courses bring complex material to life through engaging biomedical visualizations, clinical applications, and true-to-life scenarios paired with lectures from Harvard Medical School faculty and leading experts. 

Who Should Enroll

This advanced course is appropriate for clinicians and other medical professionals seeking a strong understanding of the principles of gene therapy, with practical examples of the impact and applications of these therapies in clinical settings; researchers in biomedicine and industry sectors looking for comprehensive teaching on gene therapy, with particular focus on delivery and vector design; professionals in biotechnology and health care-related fields who have an understanding of the fundamentals of genetics and would like to learn more about the relevance of gene therapy and its clinical applications. 

Course Format

Most people can expect to spend around 15–20 hours total, but this depends on your baseline knowledge, how carefully you take notes, and how seriously you take the assessments. Lessons from the courses are released toward the beginning of the course session and remain available until the courses end, so you can work at your own pace. There is a final exam at the end of each course that can be taken at any time during the multi-week final exam period. The flexible course format makes this an ideal choice for working professionals.

Additional Course Information

Overview of Gene Therapy

  • The History of Gene Therapy
  • The Promise of Gene Therapy

Introduction to Gene Therapy

  • Overview of Gene Therapy
  • Gene Therapy Vectors
  • Vector Considerations
  • Vector Design and Preparation
  • Gene Editing
  • Gene Therapy Challenges
  • Clinical Linkage: Introduction to Inherited Retinal Disorders and Adrenoleukodystrophy

Ex Vivo Gene Therapy

  • Ex Vivo Gene Therapy Indications
  • CAR T Cell Therapy
  • Vectors for Ex Vivo Gene Therapy
  • Conditioning
  • Insertional Oncogenesis
  • Clinical Linkage: Adrenoleukodystrophy

In Vivo Gene Therapy

  • In Vivo Gene Therapy Indications
  • Vectors for In Vivo Gene Therapy
  • Delivery of In Vivo Gene Therapy
  • Overcoming Challenges
  • Clinical Linkage: Inherited Retinal Disorders

Wrap-up

  • The Future of Gene Therapy

Extend Your Learning: Learn More, Save More

Whether you are building foundational medical science knowledge, preparing for advanced study, or expanding your understanding of the health care ecosystem, combining courses helps you connect concepts across disciplines while saving on enrollment.

You can bundle up to five HMX or HealthXcelerate courses. Bundle discounts apply to all courses selected. A bundle can consist of courses in the same upcoming enrollment period or the following enrollment period. 

Two-course bundle: 25% discount 
Three-course bundle: 30% discount 
Four-course bundle: 35% discount
Five-course bundle: 40% discount

View all bundle-eligible programs.

Frequently Asked Questions

Follow the link below for more information around payment and policies.

This advanced course surveys current and emerging gene therapies, including in vivo and ex vivo approaches. You’ll explore vectors, gene augmentation strategies, gene editing, and real‑world applications for conditions such as blood disorders, neurological diseases, and inherited retinal disorders.

Highlights include detailed explanations of ex vivo vs. in vivo approaches, vector selection and design, and clinical case examples that illustrate how gene therapies are developed and implemented. The course emphasizes how multidisciplinary advances are transforming patient care.

This course is ideal for clinicians, biomedical researchers, and industry professionals in pharma, biotech, and medical affairs who work with or are preparing to work with gene therapies.

This course is right for you if you work with genetic diseases, advanced therapeutics, or gene‑based technologies—or plan to transition into these areas—and need a structured, clinically grounded understanding of how gene therapies are designed, tested, and used. It’s particularly valuable if you interpret gene therapy data, communicate with patients or customers about these products, or help shape development strategies.

Typical participants include physicians (especially in hematology, neurology, ophthalmology, and pediatrics), fellows, genetic counselors, PhD‑level scientists, regulatory and medical affairs professionals, and R&D and program leaders from gene therapy and rare disease companies.

You’ll gain a clearer understanding of how gene therapies work, their risks and benefits, and their development pathways, enabling you to engage more effectively in clinical care, trial design, regulatory discussions, and product strategy. This can support advancement into specialized gene therapy roles and enhance your credibility in this highly technical field, supported by a Harvard Medical School certificate.

Gene therapy expertise often involves advanced clinical or scientific degrees plus specialized training in genetics, molecular medicine, or related disciplines, along with hands‑on experience in gene therapy research, clinical trials, or regulatory review. This course provides a structured overview that can accelerate your learning curve, prepare you for more advanced training, and help you decide how deeply to specialize in gene therapy.

Gene Therapy is a 10‑week, online, instructor‑paced course requiring about 1–2 hours per week (15–20 hours total), plus a final exam at the end of the course.

Your progress throughout the course will determine your eligibility for a Certificate of Completion from Harvard Medical School. Earning a certificate requires significant effort; learners must complete all course material by the course end date in order to qualify.

You can bundle up to five courses. Bundle discounts apply to all courses selected. A bundle can consist of courses in the same upcoming enrollment period or the following enrollment period. Bundle-eligible courses include HMX and HealthXcelerate. 

Two-course bundle: 25% discount 
Three-course bundle: 30% discount 
Four-course bundle: 35% discount
Five-course bundle: 40% discount

View all bundle-eligible programs.

Limited program fee assistance is available for participants who qualify. To apply, please submit a request via the fee assistance request form or email learn@hms.harvard.edu for more information.

Group Enrollments

HMX courses are ideal for organizations looking to train teams or larger groups. Group pricing is available, making it a cost-effective investment in team development.

Faculty

HMX courses are led by Harvard Medical School faculty, working in collaboration with a multi-disciplinary team of experts in biomedical visualization, assessment, and the science of learning to create a unique learning experience that will stay with you.

Jason Comander, MD, PhD, Assistant Professor of Ophthalmology, Harvard Medical School / Director of the Inherited Retinal Disorders Service, Massachusetts Eye and Ear

David Corey, PhD, Bertarelli Professor of Translational Medical Science, Harvard Medical School

Florian Eichler, MD, Associate Professor of Neurology, Harvard Medical School / Neurologist and Director of the Leukodystrophy Service, Massachusetts General Hospital

Erica Esrick, MD, Instructor in Pediatrics, Harvard Medical School / Pediatric Hematologist, Boston Children’s Hospital

Rachel Huckfeldt, MD, PhD, Assistant Professor of Ophthalmology, Harvard Medical School / Ophthalmologist, Massachusetts Eye and Ear / Director of the Inherited Retinal Degenerations Fellowship, Massachusetts Eye and Ear

Patricia Musolino, MD, PhD, Assistant Professor of Neurology, Harvard Medical School / Neurologist, Massachusetts General Hospital / Co-Director of the Pediatric Stroke and Cerebrovascular Service, Massachusetts General Hospital / Faculty, Center for Genomic Medicine, Massachusetts General Hospital

David Williams, MD, Leland Fikes Professor of Pediatrics, Harvard Medical School / Chief of the Division of Hematology/Oncology, Boston Children’s Hospital / Associate Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute

ADDITIONAL CONTRIBUTORS

Jillian F. Wise, PhD, Instructor in Investigation, Massachusetts General Hospital / Harvard Medical School / Broad Institute

Jordan Said, MD, Internal Medicine Resident, Brigham and Women’s Hospital / Harvard Medical School

Allie Stanton, PhD Candidate, Harvard Medical School

Course Quiz

Are you ready for an advanced course? We recommend knowledge of basic chemistry, biology, and physics, as well as knowledge of key genetics concepts. Gauge your knowledge of genetics by taking this short quiz.

Not Sure Which Course Is Right for You?

Compare HMX genetics-related offerings side by side and find the best fit for your goals.

From Our Learners

Hear from HMX students as they share their experiences learning online with Harvard Medical School.

"These are the best online courses I have ever taken by far. Nothing compares to how much knowledge I have gained from these courses."

Explore Related Programs

Bundle courses together for discounted pricing.

Genetics Essentials

Get essential genetics knowledge to prepare for the future of health care.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option
  • Registration Deadline Approaching:

Dates: -

For: Health care professionals working in roles such as R&D, product management and strategy, sales, and marketing

Genetic Testing and Sequencing Technologies

Explore recent advances in genetic testing and learn about the implications for patient care.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option
  • Registration Deadline Approaching:

Dates: -

For: Clinicians and other medical professionals; researchers in biomedicine and industry sectors; professionals in biotechnology and health care-related fields

Cancer Genomics and Precision Oncology: The Genetic Basis of Cancer and Its Treatment

Understand the links between genetics and cancer, and how genomics knowledge is advancing precision cancer treatments.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option
  • Registration Deadline Approaching:

Dates: -

For: Clinicians; biomedical researchers; health care professionals whose work intersects with cancer research and treatment – including those working in R&D, product management and strategy, sales, and marketing

Nucleic Acid Therapeutics: Existing and Emerging Approaches for Managing and Treating Diseases

Learn how nucleic acid therapeutics can be used to treat, prevent, and cure diseases.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option
  • Registration Deadline Approaching:

Dates: -

For: Clinicians and other medical professionals; biomedical researchers, professors, and academics within or adjacent to the field of genetics; professionals in the biopharmaceutical and related industries

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics